Drug-eluting stents appear superior to bare metal stents for vein-graft PCI in vessels up to a stent diameter of 4 mm
BackgroundResearch trials have shown improved short-term outcome with drug-eluting stents (DES) over bare metal stents (BMS) in saphenous vein graft (SVG) percutaneous coronary intervention (PCI), primarily by reducing target vessel revascularization (TVR) for in-stent restenosis. We compared the ou...
Main Authors: | Oliver P. Guttmann, Daniel A. Jones, Kassem A. Safwan, Sean Gallagher, Krishnaraj S. Rathod, Steve Hamshere, Elliot J. Smith, Ajay K. Jain, Anthony Mathur, Andrew Wragg, Charles J. Knight, Roshan Weerackody |
---|---|
Format: | Article |
Language: | English |
Published: |
Touch Medical Media
2016-05-01
|
Series: | Heart International |
Online Access: | http://www.heart-int.com/Attach/1B069907-E827-40E4-B6B2-A9DEBF6EDDB0/0D901FE4-6202-4EA6-85A6-7749C29F66A7 |
Similar Items
-
Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
by: Negar Faramarzi, et al.
Published: (2015-10-01) -
Drug-eluting versus bare-metal stents in primary PCI. Analysis of an 8-year registry
by: Alfredo Redondo Diéguez, et al.
Published: (2019-02-01) -
Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting
by: Damian Maciejewski, et al.
Published: (2019-09-01) -
Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
by: Kakhaber Etsadashvili, et al.
Published: (2011-06-01) -
Clinical Outcomes and Costs for Patients with Drug-Eluting Stents vs. Bare Metal Stents
by: Tzu-Ching Chen, et al.
Published: (2014)